CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.57 -0.21 (-5.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

CollPlant Biotechnologies (CLGN) Return on Equity [ROE] (2018 - 2025)

Updated

CollPlant Biotechnologies (CLGN) recorded Return on Equity [ROE] of -68.89% in the quarter ended Dec 31, 2025, down 14.09 percentage points from -54.80% a year earlier but up 64.56 percentage points from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Return on Equity [ROE] (2018 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, CollPlant Biotechnologies reported Return on Equity [ROE] of -117.56%, down 38.10 percentage points from the prior year.

  • Annual Return on Equity [ROE] has a five-year change of -252.39 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Equity [ROE] came in at -79.46% in the year ended Dec 31, 2024 (-56.30 pp), -23.16% in the year ended Dec 31, 2023 (+20.58 pp), -43.73% in the year ended Dec 31, 2022 (-44.88 pp) and 1.15% in the year ended Dec 31, 2021 (-133.68 pp).
  • Quarterly Return on Equity [ROE] has ranged from -133.45% in the quarter ended Sep 30, 2025 to 77.68% in the quarter ended Mar 31, 2021 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] rose in three of the last six quarters, with an average year-over-year change of -17.76 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 57.27 percentage points in the quarter ended Mar 31, 2024, against a drop of 323.40 percentage points in the quarter ended Sep 30, 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 CollPlant Biotechnologies 4.74 Mn -24.70 Mn -456,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -68.89%
Sep 30, 2025 -133.45%
Dec 31, 2024 -54.80%
Sep 30, 2024 -2.20%
Jun 30, 2024 -2.06%
Mar 31, 2024 3.05%
Dec 31, 2023 1.07%
Sep 30, 2023 -20.43%
Jun 30, 2023 -21.21%
Mar 31, 2023 -54.22%
Dec 31, 2022 -49.08%
Sep 30, 2022 -22.51%
Jun 30, 2022 -17.21%
Mar 31, 2022 -13.40%
Dec 31, 2021 0.68%
Sep 30, 2021 26.01%
Jun 30, 2021 32.89%
Mar 31, 2021 77.68%
Dec 31, 2020 227.59%
Sep 30, 2020 349.42%
API Access

CollPlant Biotechnologies Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLGN&period=max&api_key=YOUR_API_KEY